Education
About Us
Working with TipRanks
Follow Us
4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
FDMT Analyst Ratings
Strong Buy
4 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
FDMT Stock 12 Month Forecast
Average Price Target
$36.25
▲(327.48% Upside)
| Highest Price Target$45.00 | Average Price Target$36.25 | Lowest Price Target$31.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Bank of America Securities
$31
Buy
265.57%
Upside
Reiterated
01/27/26
Barclays
$33
Buy
289.15%
Upside
Reiterated
01/27/26
H.C. Wainwright
$36
Buy
324.53%
Upside
Reiterated
12/18/25
Evercore ISI
$45
Buy
430.66%
Upside
Reiterated
12/18/25
Morgan Stanley
―
Hold
―
Reiterated
12/17/25
Chardan Capital
$26
Buy
206.60%
Upside
Reiterated
11/10/25
RBC Capital
$26→$32
Buy
277.36%
Upside
Reiterated
11/10/25
Goldman Sachs
$44→$38
Buy
348.11%
Upside
Reiterated
08/12/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Bank of America Securities
$31
Buy
265.57%
Upside
Reiterated
01/27/26
Barclays
$33
Buy
289.15%
Upside
Reiterated
01/27/26
H.C. Wainwright
$36
Buy
324.53%
Upside
Reiterated
12/18/25
Evercore ISI
$45
Buy
430.66%
Upside
Reiterated
12/18/25
Morgan Stanley
―
Hold
―
Reiterated
12/17/25
Chardan Capital
$26
Buy
206.60%
Upside
Reiterated
11/10/25
RBC Capital
$26→$32
Buy
277.36%
Upside
Reiterated
11/10/25
Goldman Sachs
$44→$38
Buy
348.11%
Upside
Reiterated
08/12/25
Best Analysts Covering 4D Molecular Therapeutics
3 Months
xxx
Success Rate
7/17 ratings generated profit
Average Return
+1.38%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 41.18% of your transactions generating a profit, with an average return of +1.38% per trade.
1 Year
Success Rate
12/24 ratings generated profit
Average Return
+7.36%
reiterated a buy rating 3 months ago
Copying Matthew Caufield's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +7.36% per trade.
2 Years
xxx
Success Rate
7/17 ratings generated profit
Average Return
-4.91%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 41.18% of your transactions generating a profit, with an average return of -4.91% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
FDMT Analyst Recommendation Trends
Rating
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
15
11
12
12
6
Buy
1
2
3
2
1
Hold
9
14
19
30
35
Sell
2
1
1
0
0
Strong Sell
0
0
0
0
0
total
27
28
35
44
42
Each month's total comprises the sum of three months' worth of ratings.
FDMT Financial Forecast
FDMT Stock Forecast FAQ
What is FDMT’s average 12-month price target, according to analysts?
Based on analyst ratings, 4D Molecular Therapeutics’s 12-month average price target is 36.25.
What is FDMT’s upside potential, based on the analysts’ average price target?
4D Molecular Therapeutics has 327.48% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is FDMT a Buy, Sell or Hold?
4D Molecular Therapeutics has a consensus rating of Strong Buy which is based on 4 buy ratings, 1 hold ratings and 0 sell ratings.
What is 4D Molecular Therapeutics’s price target?
The average price target for 4D Molecular Therapeutics is 36.25. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $45.00 ,the lowest forecast is $31.00. The average price target represents 327.48% Increase from the current price of $8.48.
The highest analyst price target is $45.00 ,the lowest forecast is $31.00. The average price target represents 327.48% Increase from the current price of $8.48.
What do analysts say about 4D Molecular Therapeutics?
4D Molecular Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
How can I buy shares of FDMT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.